Compile Data Set for Download or QSAR
maximum 50k data

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)

Found 10 hits in this display   

TargetComplement factor B(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489636(US10961252, Cmp No. 22 | US11248000, Cmp No. 22 | ...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor B(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489646((R)-imino(4-((2S,4R)- 1-((5-methoxy-7- methyl-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489645((S)-imino(4-((2S,4R)- 1-((5-methoxy-7- methyl-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor B(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489640(US10961252, Cmp No. 25 | US11248000, Cmp No. 25 | ...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor B(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489645((S)-imino(4-((2S,4R)- 1-((5-methoxy-7- methyl-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489646((R)-imino(4-((2S,4R)- 1-((5-methoxy-7- methyl-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489636(US10961252, Cmp No. 22 | US11248000, Cmp No. 22 | ...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489640(US10961252, Cmp No. 25 | US11248000, Cmp No. 25 | ...)
Affinity DataIC50: <1.00E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489637(US10961252, Cmp No. 23 | US11248000, Cmp No. 23 | ...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetComplement factor B(Homo sapiens (Human))
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM489637(US10961252, Cmp No. 23 | US11248000, Cmp No. 23 | ...)
Affinity DataIC50: >1.00E+4nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent